Abstract

Babies are still being affected by rhesus D haemolytic disease despite the introduction of anti-D immunoglobulin prophylaxis more than a decade ago. In 1983 at least 34 babies died from the disease in the UK¹ and 600–800 rhesus D (RhD) negative pregnant women become sensitised each year.² What can be done to prevent this unnecessary illness and death?